A Historic Milestone in Local Biotechnological API Production!

Turning Another Dream into Reality: A Historic Milestone in Local Biotechnological API Production!
We are proud to announce that we now produce, right here in Türkiye, the active pharmaceutical ingredient (API) of a critical biotechnological protein that had been imported for years costing the country over $200 million in the past five years.

At our Çerkezköy facilities
We successfully completed the production of the API,
Finalized the formulation processes, including filling in vial, cartridge, and pen forms,
Concluded all quality control studies, and
Submitted our marketing authorization pre-application to the regulatory authority.

This product has now become the second biotechnological molecule in Türkiye for which both the API production and regulatory application have been completed locally. By developing the biosimilar version of this product  which has faced periodic supply shortages in the country we are taking a major step toward delivering a reliable, domestic solution to public health needs.

Our goal is clear: We aim to develop and manufacture biotechnological medicines from the raw material stage, fully locally and nationally.
We extend our heartfelt thanks to all our team members, partners, and everyone who contributed throughout this journey  from R&D to production, from quality assurance to regulatory affairs.

We will continue to work tirelessly to strengthen our healthcare system through local innovation and manufacturing.